Request for Covid-19 Impact Assessment of this Report
The United States Tetrahydrocannabinol (THC) and Cannabidiol (CBD) market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) market, reaching US$ million by the year 2028. As for the Europe Tetrahydrocannabinol (THC) and Cannabidiol (CBD) landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Tetrahydrocannabinol (THC) and Cannabidiol (CBD) players cover Kazmira, CW Hemp/CW Botanicals, Freedom Leaf, and Green Road, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Tetrahydrocannabinol (THC) and Cannabidiol (CBD) market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Tetrahydrocannabinol (THC)
Cannabidiol (CBD)
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Pharmaceuticals Industry
Food Industry
Cosmetics Industry
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Kazmira
CW Hemp/CW Botanicals
Freedom Leaf
Green Road
Medical Marijuana
Folium Biosciences
HempLife Today
Cannavest
Pharmahemp
ENDOCA
CBD American Shaman
NuLeaf Naturals
Select Oil
K.I.N.D. Concentrates
Canopy Growth Corporation
Aphria
Emblem Cannabis Oils
Whistler
The Lab
Absolute Terps
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Tetrahydrocannabinol (THC) and Cannabidiol (CBD) by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Tetrahydrocannabinol (THC) and Cannabidiol (CBD) by Country/Region, 2017, 2022 & 2028
2.2 Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Segment by Type
2.2.1 Tetrahydrocannabinol (THC)
2.2.2 Cannabidiol (CBD)
2.3 Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Type
2.3.1 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Market Share by Type (2017-2022)
2.3.2 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue and Market Share by Type (2017-2022)
2.3.3 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sale Price by Type (2017-2022)
2.4 Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Segment by Application
2.4.1 Pharmaceuticals Industry
2.4.2 Food Industry
2.4.3 Cosmetics Industry
2.4.4 Other
2.5 Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Application
2.5.1 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sale Market Share by Application (2017-2022)
2.5.2 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue and Market Share by Application (2017-2022)
2.5.3 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sale Price by Application (2017-2022)
3 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) by Company
3.1 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Breakdown Data by Company
3.1.1 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Annual Sales by Company (2020-2022)
3.1.2 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Market Share by Company (2020-2022)
3.2 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Annual Revenue by Company (2020-2022)
3.2.1 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue by Company (2020-2022)
3.2.2 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Market Share by Company (2020-2022)
3.3 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sale Price by Company
3.4 Key Manufacturers Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Location Distribution
3.4.2 Players Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Tetrahydrocannabinol (THC) and Cannabidiol (CBD) by Geographic Region
4.1 World Historic Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market Size by Geographic Region (2017-2022)
4.1.1 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Annual Revenue by Geographic Region
4.2 World Historic Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market Size by Country/Region (2017-2022)
4.2.1 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Annual Sales by Country/Region (2017-2022)
4.2.2 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Annual Revenue by Country/Region
4.3 Americas Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Growth
4.4 APAC Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Growth
4.5 Europe Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Growth
4.6 Middle East & Africa Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Growth
5 Americas
5.1 Americas Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Country
5.1.1 Americas Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Country (2017-2022)
5.1.2 Americas Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue by Country (2017-2022)
5.2 Americas Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Type
5.3 Americas Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Region
6.1.1 APAC Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Region (2017-2022)
6.1.2 APAC Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue by Region (2017-2022)
6.2 APAC Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Type
6.3 APAC Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Tetrahydrocannabinol (THC) and Cannabidiol (CBD) by Country
7.1.1 Europe Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Country (2017-2022)
7.1.2 Europe Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue by Country (2017-2022)
7.2 Europe Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Type
7.3 Europe Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Tetrahydrocannabinol (THC) and Cannabidiol (CBD) by Country
8.1.1 Middle East & Africa Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Country (2017-2022)
8.1.2 Middle East & Africa Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue by Country (2017-2022)
8.2 Middle East & Africa Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Type
8.3 Middle East & Africa Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Tetrahydrocannabinol (THC) and Cannabidiol (CBD)
10.3 Manufacturing Process Analysis of Tetrahydrocannabinol (THC) and Cannabidiol (CBD)
10.4 Industry Chain Structure of Tetrahydrocannabinol (THC) and Cannabidiol (CBD)
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Distributors
11.3 Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Customer
12 World Forecast Review for Tetrahydrocannabinol (THC) and Cannabidiol (CBD) by Geographic Region
12.1 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market Size Forecast by Region
12.1.1 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Forecast by Region (2023-2028)
12.1.2 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Forecast by Type
12.7 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Forecast by Application
13 Key Players Analysis
13.1 Kazmira
13.1.1 Kazmira Company Information
13.1.2 Kazmira Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Offered
13.1.3 Kazmira Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Kazmira Main Business Overview
13.1.5 Kazmira Latest Developments
13.2 CW Hemp/CW Botanicals
13.2.1 CW Hemp/CW Botanicals Company Information
13.2.2 CW Hemp/CW Botanicals Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Offered
13.2.3 CW Hemp/CW Botanicals Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 CW Hemp/CW Botanicals Main Business Overview
13.2.5 CW Hemp/CW Botanicals Latest Developments
13.3 Freedom Leaf
13.3.1 Freedom Leaf Company Information
13.3.2 Freedom Leaf Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Offered
13.3.3 Freedom Leaf Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Freedom Leaf Main Business Overview
13.3.5 Freedom Leaf Latest Developments
13.4 Green Road
13.4.1 Green Road Company Information
13.4.2 Green Road Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Offered
13.4.3 Green Road Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Green Road Main Business Overview
13.4.5 Green Road Latest Developments
13.5 Medical Marijuana
13.5.1 Medical Marijuana Company Information
13.5.2 Medical Marijuana Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Offered
13.5.3 Medical Marijuana Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Medical Marijuana Main Business Overview
13.5.5 Medical Marijuana Latest Developments
13.6 Folium Biosciences
13.6.1 Folium Biosciences Company Information
13.6.2 Folium Biosciences Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Offered
13.6.3 Folium Biosciences Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Folium Biosciences Main Business Overview
13.6.5 Folium Biosciences Latest Developments
13.7 HempLife Today
13.7.1 HempLife Today Company Information
13.7.2 HempLife Today Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Offered
13.7.3 HempLife Today Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 HempLife Today Main Business Overview
13.7.5 HempLife Today Latest Developments
13.8 Cannavest
13.8.1 Cannavest Company Information
13.8.2 Cannavest Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Offered
13.8.3 Cannavest Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Cannavest Main Business Overview
13.8.5 Cannavest Latest Developments
13.9 Pharmahemp
13.9.1 Pharmahemp Company Information
13.9.2 Pharmahemp Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Offered
13.9.3 Pharmahemp Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Pharmahemp Main Business Overview
13.9.5 Pharmahemp Latest Developments
13.10 ENDOCA
13.10.1 ENDOCA Company Information
13.10.2 ENDOCA Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Offered
13.10.3 ENDOCA Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 ENDOCA Main Business Overview
13.10.5 ENDOCA Latest Developments
13.11 CBD American Shaman
13.11.1 CBD American Shaman Company Information
13.11.2 CBD American Shaman Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Offered
13.11.3 CBD American Shaman Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 CBD American Shaman Main Business Overview
13.11.5 CBD American Shaman Latest Developments
13.12 NuLeaf Naturals
13.12.1 NuLeaf Naturals Company Information
13.12.2 NuLeaf Naturals Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Offered
13.12.3 NuLeaf Naturals Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 NuLeaf Naturals Main Business Overview
13.12.5 NuLeaf Naturals Latest Developments
13.13 Select Oil
13.13.1 Select Oil Company Information
13.13.2 Select Oil Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Offered
13.13.3 Select Oil Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Select Oil Main Business Overview
13.13.5 Select Oil Latest Developments
13.14 K.I.N.D. Concentrates
13.14.1 K.I.N.D. Concentrates Company Information
13.14.2 K.I.N.D. Concentrates Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Offered
13.14.3 K.I.N.D. Concentrates Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 K.I.N.D. Concentrates Main Business Overview
13.14.5 K.I.N.D. Concentrates Latest Developments
13.15 Canopy Growth Corporation
13.15.1 Canopy Growth Corporation Company Information
13.15.2 Canopy Growth Corporation Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Offered
13.15.3 Canopy Growth Corporation Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales, Revenue, Price and Gross Margin (2020-2022)
13.15.4 Canopy Growth Corporation Main Business Overview
13.15.5 Canopy Growth Corporation Latest Developments
13.16 Aphria
13.16.1 Aphria Company Information
13.16.2 Aphria Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Offered
13.16.3 Aphria Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales, Revenue, Price and Gross Margin (2020-2022)
13.16.4 Aphria Main Business Overview
13.16.5 Aphria Latest Developments
13.17 Emblem Cannabis Oils
13.17.1 Emblem Cannabis Oils Company Information
13.17.2 Emblem Cannabis Oils Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Offered
13.17.3 Emblem Cannabis Oils Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales, Revenue, Price and Gross Margin (2020-2022)
13.17.4 Emblem Cannabis Oils Main Business Overview
13.17.5 Emblem Cannabis Oils Latest Developments
13.18 Whistler
13.18.1 Whistler Company Information
13.18.2 Whistler Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Offered
13.18.3 Whistler Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales, Revenue, Price and Gross Margin (2020-2022)
13.18.4 Whistler Main Business Overview
13.18.5 Whistler Latest Developments
13.19 The Lab
13.19.1 The Lab Company Information
13.19.2 The Lab Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Offered
13.19.3 The Lab Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales, Revenue, Price and Gross Margin (2020-2022)
13.19.4 The Lab Main Business Overview
13.19.5 The Lab Latest Developments
13.20 Absolute Terps
13.20.1 Absolute Terps Company Information
13.20.2 Absolute Terps Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Offered
13.20.3 Absolute Terps Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales, Revenue, Price and Gross Margin (2020-2022)
13.20.4 Absolute Terps Main Business Overview
13.20.5 Absolute Terps Latest Developments
14 Research Findings and Conclusion
Table 1. Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Tetrahydrocannabinol (THC)
Table 4. Major Players of Cannabidiol (CBD)
Table 5. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Type (2017-2022) & (MT)
Table 6. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Market Share by Type (2017-2022)
Table 7. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue by Type (2017-2022) & ($ million)
Table 8. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Market Share by Type (2017-2022)
Table 9. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sale Price by Type (2017-2022) & (US$/kg)
Table 10. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Application (2017-2022) & (MT)
Table 11. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Market Share by Application (2017-2022)
Table 12. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue by Application (2017-2022)
Table 13. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Market Share by Application (2017-2022)
Table 14. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sale Price by Application (2017-2022) & (US$/kg)
Table 15. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Company (2020-2022) & (MT)
Table 16. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Market Share by Company (2020-2022)
Table 17. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Market Share by Company (2020-2022)
Table 19. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sale Price by Company (2020-2022) & (US$/kg)
Table 20. Key Manufacturers Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Producing Area Distribution and Sales Area
Table 21. Players Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Products Offered
Table 22. Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Geographic Region (2017-2022) & (MT)
Table 26. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Market Share Geographic Region (2017-2022)
Table 27. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Country/Region (2017-2022) & (MT)
Table 30. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Market Share by Country/Region (2017-2022)
Table 31. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Country (2017-2022) & (MT)
Table 34. Americas Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Market Share by Country (2017-2022)
Table 35. Americas Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Market Share by Country (2017-2022)
Table 37. Americas Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Type (2017-2022) & (MT)
Table 38. Americas Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Market Share by Type (2017-2022)
Table 39. Americas Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Application (2017-2022) & (MT)
Table 40. Americas Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Market Share by Application (2017-2022)
Table 41. APAC Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Region (2017-2022) & (MT)
Table 42. APAC Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Market Share by Region (2017-2022)
Table 43. APAC Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Market Share by Region (2017-2022)
Table 45. APAC Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Type (2017-2022) & (MT)
Table 46. APAC Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Market Share by Type (2017-2022)
Table 47. APAC Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Application (2017-2022) & (MT)
Table 48. APAC Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Market Share by Application (2017-2022)
Table 49. Europe Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Country (2017-2022) & (MT)
Table 50. Europe Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Market Share by Country (2017-2022)
Table 51. Europe Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Market Share by Country (2017-2022)
Table 53. Europe Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Type (2017-2022) & (MT)
Table 54. Europe Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Market Share by Type (2017-2022)
Table 55. Europe Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Application (2017-2022) & (MT)
Table 56. Europe Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Country (2017-2022) & (MT)
Table 58. Middle East & Africa Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Type (2017-2022) & (MT)
Table 62. Middle East & Africa Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Application (2017-2022) & (MT)
Table 64. Middle East & Africa Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Tetrahydrocannabinol (THC) and Cannabidiol (CBD)
Table 66. Key Market Challenges & Risks of Tetrahydrocannabinol (THC) and Cannabidiol (CBD)
Table 67. Key Industry Trends of Tetrahydrocannabinol (THC) and Cannabidiol (CBD)
Table 68. Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Distributors List
Table 71. Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Customer List
Table 72. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Forecast by Region (2023-2028) & (MT)
Table 73. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Market Forecast by Region
Table 74. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Forecast by Country (2023-2028) & (MT)
Table 77. Americas Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Forecast by Region (2023-2028) & (MT)
Table 79. APAC Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Forecast by Country (2023-2028) & (MT)
Table 81. Europe Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Forecast by Country (2023-2028) & (MT)
Table 83. Middle East & Africa Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Forecast by Type (2023-2028) & (MT)
Table 85. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Forecast by Application (2023-2028) & (MT)
Table 89. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Market Share Forecast by Application (2023-2028)
Table 92. Kazmira Basic Information, Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Manufacturing Base, Sales Area and Its Competitors
Table 93. Kazmira Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Offered
Table 94. Kazmira Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales (MT), Revenue ($ Million), Price (US$/kg) and Gross Margin (2020-2022)
Table 95. Kazmira Main Business
Table 96. Kazmira Latest Developments
Table 97. CW Hemp/CW Botanicals Basic Information, Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Manufacturing Base, Sales Area and Its Competitors
Table 98. CW Hemp/CW Botanicals Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Offered
Table 99. CW Hemp/CW Botanicals Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales (MT), Revenue ($ Million), Price (US$/kg) and Gross Margin (2020-2022)
Table 100. CW Hemp/CW Botanicals Main Business
Table 101. CW Hemp/CW Botanicals Latest Developments
Table 102. Freedom Leaf Basic Information, Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Manufacturing Base, Sales Area and Its Competitors
Table 103. Freedom Leaf Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Offered
Table 104. Freedom Leaf Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales (MT), Revenue ($ Million), Price (US$/kg) and Gross Margin (2020-2022)
Table 105. Freedom Leaf Main Business
Table 106. Freedom Leaf Latest Developments
Table 107. Green Road Basic Information, Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Manufacturing Base, Sales Area and Its Competitors
Table 108. Green Road Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Offered
Table 109. Green Road Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales (MT), Revenue ($ Million), Price (US$/kg) and Gross Margin (2020-2022)
Table 110. Green Road Main Business
Table 111. Green Road Latest Developments
Table 112. Medical Marijuana Basic Information, Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Manufacturing Base, Sales Area and Its Competitors
Table 113. Medical Marijuana Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Offered
Table 114. Medical Marijuana Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales (MT), Revenue ($ Million), Price (US$/kg) and Gross Margin (2020-2022)
Table 115. Medical Marijuana Main Business
Table 116. Medical Marijuana Latest Developments
Table 117. Folium Biosciences Basic Information, Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Manufacturing Base, Sales Area and Its Competitors
Table 118. Folium Biosciences Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Offered
Table 119. Folium Biosciences Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales (MT), Revenue ($ Million), Price (US$/kg) and Gross Margin (2020-2022)
Table 120. Folium Biosciences Main Business
Table 121. Folium Biosciences Latest Developments
Table 122. HempLife Today Basic Information, Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Manufacturing Base, Sales Area and Its Competitors
Table 123. HempLife Today Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Offered
Table 124. HempLife Today Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales (MT), Revenue ($ Million), Price (US$/kg) and Gross Margin (2020-2022)
Table 125. HempLife Today Main Business
Table 126. HempLife Today Latest Developments
Table 127. Cannavest Basic Information, Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Manufacturing Base, Sales Area and Its Competitors
Table 128. Cannavest Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Offered
Table 129. Cannavest Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales (MT), Revenue ($ Million), Price (US$/kg) and Gross Margin (2020-2022)
Table 130. Cannavest Main Business
Table 131. Cannavest Latest Developments
Table 132. Pharmahemp Basic Information, Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Manufacturing Base, Sales Area and Its Competitors
Table 133. Pharmahemp Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Offered
Table 134. Pharmahemp Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales (MT), Revenue ($ Million), Price (US$/kg) and Gross Margin (2020-2022)
Table 135. Pharmahemp Main Business
Table 136. Pharmahemp Latest Developments
Table 137. ENDOCA Basic Information, Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Manufacturing Base, Sales Area and Its Competitors
Table 138. ENDOCA Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Offered
Table 139. ENDOCA Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales (MT), Revenue ($ Million), Price (US$/kg) and Gross Margin (2020-2022)
Table 140. ENDOCA Main Business
Table 141. ENDOCA Latest Developments
Table 142. CBD American Shaman Basic Information, Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Manufacturing Base, Sales Area and Its Competitors
Table 143. CBD American Shaman Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Offered
Table 144. CBD American Shaman Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales (MT), Revenue ($ Million), Price (US$/kg) and Gross Margin (2020-2022)
Table 145. CBD American Shaman Main Business
Table 146. CBD American Shaman Latest Developments
Table 147. NuLeaf Naturals Basic Information, Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Manufacturing Base, Sales Area and Its Competitors
Table 148. NuLeaf Naturals Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Offered
Table 149. NuLeaf Naturals Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales (MT), Revenue ($ Million), Price (US$/kg) and Gross Margin (2020-2022)
Table 150. NuLeaf Naturals Main Business
Table 151. NuLeaf Naturals Latest Developments
Table 152. Select Oil Basic Information, Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Manufacturing Base, Sales Area and Its Competitors
Table 153. Select Oil Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Offered
Table 154. Select Oil Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales (MT), Revenue ($ Million), Price (US$/kg) and Gross Margin (2020-2022)
Table 155. Select Oil Main Business
Table 156. Select Oil Latest Developments
Table 157. K.I.N.D. Concentrates Basic Information, Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Manufacturing Base, Sales Area and Its Competitors
Table 158. K.I.N.D. Concentrates Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Offered
Table 159. K.I.N.D. Concentrates Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales (MT), Revenue ($ Million), Price (US$/kg) and Gross Margin (2020-2022)
Table 160. K.I.N.D. Concentrates Main Business
Table 161. K.I.N.D. Concentrates Latest Developments
Table 162. Canopy Growth Corporation Basic Information, Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Manufacturing Base, Sales Area and Its Competitors
Table 163. Canopy Growth Corporation Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Offered
Table 164. Canopy Growth Corporation Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales (MT), Revenue ($ Million), Price (US$/kg) and Gross Margin (2020-2022)
Table 165. Canopy Growth Corporation Main Business
Table 166. Canopy Growth Corporation Latest Developments
Table 167. Aphria Basic Information, Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Manufacturing Base, Sales Area and Its Competitors
Table 168. Aphria Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Offered
Table 169. Aphria Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales (MT), Revenue ($ Million), Price (US$/kg) and Gross Margin (2020-2022)
Table 170. Aphria Main Business
Table 171. Aphria Latest Developments
Table 172. Emblem Cannabis Oils Basic Information, Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Manufacturing Base, Sales Area and Its Competitors
Table 173. Emblem Cannabis Oils Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Offered
Table 174. Emblem Cannabis Oils Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales (MT), Revenue ($ Million), Price (US$/kg) and Gross Margin (2020-2022)
Table 175. Emblem Cannabis Oils Main Business
Table 176. Emblem Cannabis Oils Latest Developments
Table 177. Whistler Basic Information, Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Manufacturing Base, Sales Area and Its Competitors
Table 178. Whistler Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Offered
Table 179. Whistler Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales (MT), Revenue ($ Million), Price (US$/kg) and Gross Margin (2020-2022)
Table 180. Whistler Main Business
Table 181. Whistler Latest Developments
Table 182. The Lab Basic Information, Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Manufacturing Base, Sales Area and Its Competitors
Table 183. The Lab Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Offered
Table 184. The Lab Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales (MT), Revenue ($ Million), Price (US$/kg) and Gross Margin (2020-2022)
Table 185. The Lab Main Business
Table 186. The Lab Latest Developments
Table 187. Absolute Terps Basic Information, Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Manufacturing Base, Sales Area and Its Competitors
Table 188. Absolute Terps Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Offered
Table 189. Absolute Terps Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales (MT), Revenue ($ Million), Price (US$/kg) and Gross Margin (2020-2022)
Table 190. Absolute Terps Main Business
Table 191. Absolute Terps Latest Developments
List of Figures
Figure 1. Picture of Tetrahydrocannabinol (THC) and Cannabidiol (CBD)
Figure 2. Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Growth Rate 2017-2028 (MT)
Figure 7. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Tetrahydrocannabinol (THC)
Figure 10. Product Picture of Cannabidiol (CBD)
Figure 11. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Market Share by Type in 2021
Figure 12. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Market Share by Type (2017-2022)
Figure 13. Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Consumed in Pharmaceuticals Industry
Figure 14. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market: Pharmaceuticals Industry (2017-2022) & (MT)
Figure 15. Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Consumed in Food Industry
Figure 16. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market: Food Industry (2017-2022) & (MT)
Figure 17. Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Consumed in Cosmetics Industry
Figure 18. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market: Cosmetics Industry (2017-2022) & (MT)
Figure 19. Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Consumed in Other
Figure 20. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market: Other (2017-2022) & (MT)
Figure 21. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Market Share by Application (2017-2022)
Figure 22. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Market Share by Application in 2021
Figure 23. Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Market by Company in 2021 ($ Million)
Figure 24. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Market Share by Company in 2021
Figure 25. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Market Share by Geographic Region (2017-2022)
Figure 26. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Market Share by Geographic Region in 2021
Figure 27. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Market Share by Region (2017-2022)
Figure 28. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Market Share by Country/Region in 2021
Figure 29. Americas Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales 2017-2022 (MT)
Figure 30. Americas Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue 2017-2022 ($ Millions)
Figure 31. APAC Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales 2017-2022 (MT)
Figure 32. APAC Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue 2017-2022 ($ Millions)
Figure 33. Europe Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales 2017-2022 (MT)
Figure 34. Europe Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue 2017-2022 ($ Millions)
Figure 35. Middle East & Africa Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales 2017-2022 (MT)
Figure 36. Middle East & Africa Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue 2017-2022 ($ Millions)
Figure 37. Americas Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Market Share by Country in 2021
Figure 38. Americas Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Market Share by Country in 2021
Figure 39. United States Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Growth 2017-2022 ($ Millions)
Figure 40. Canada Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Growth 2017-2022 ($ Millions)
Figure 41. Mexico Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Growth 2017-2022 ($ Millions)
Figure 42. Brazil Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Growth 2017-2022 ($ Millions)
Figure 43. APAC Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Market Share by Region in 2021
Figure 44. APAC Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Market Share by Regions in 2021
Figure 45. China Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Growth 2017-2022 ($ Millions)
Figure 46. Japan Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Growth 2017-2022 ($ Millions)
Figure 47. South Korea Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Growth 2017-2022 ($ Millions)
Figure 48. Southeast Asia Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Growth 2017-2022 ($ Millions)
Figure 49. India Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Growth 2017-2022 ($ Millions)
Figure 50. Australia Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Growth 2017-2022 ($ Millions)
Figure 51. Europe Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Market Share by Country in 2021
Figure 52. Europe Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Market Share by Country in 2021
Figure 53. Germany Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Growth 2017-2022 ($ Millions)
Figure 54. France Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Growth 2017-2022 ($ Millions)
Figure 55. UK Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Growth 2017-2022 ($ Millions)
Figure 56. Italy Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Growth 2017-2022 ($ Millions)
Figure 57. Russia Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Growth 2017-2022 ($ Millions)
Figure 58. Middle East & Africa Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Market Share by Country in 2021
Figure 59. Middle East & Africa Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Market Share by Country in 2021
Figure 60. Egypt Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Growth 2017-2022 ($ Millions)
Figure 61. South Africa Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Growth 2017-2022 ($ Millions)
Figure 62. Israel Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Growth 2017-2022 ($ Millions)
Figure 63. Turkey Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Growth 2017-2022 ($ Millions)
Figure 64. GCC Country Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Growth 2017-2022 ($ Millions)
Figure 65. Manufacturing Cost Structure Analysis of Tetrahydrocannabinol (THC) and Cannabidiol (CBD) in 2021
Figure 66. Manufacturing Process Analysis of Tetrahydrocannabinol (THC) and Cannabidiol (CBD)
Figure 67. Industry Chain Structure of Tetrahydrocannabinol (THC) and Cannabidiol (CBD)
Figure 68. Channels of Distribution
Figure 69. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...